These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11792319)

  • 1. DREAM is a critical transcriptional repressor for pain modulation.
    Cheng HY; Pitcher GM; Laviolette SR; Whishaw IQ; Tong KI; Kockeritz LK; Wada T; Joza NA; Crackower M; Goncalves J; Sarosi I; Woodgett JR; Oliveira-dos-Santos AJ; Ikura M; van der Kooy D; Salter MW; Penninger JM
    Cell; 2002 Jan; 108(1):31-43. PubMed ID: 11792319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression.
    Jacobson DA; Cho J; Landa LR; Tamarina NA; Roe MW; Buxbaum JD; Philipson LH
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E587-95. PubMed ID: 16621893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking out the DREAM to study pain.
    Vogt BA
    N Engl J Med; 2002 Aug; 347(5):362-4. PubMed ID: 12151476
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When the DREAM is gone: from basic science to future prospectives in pain management and beyond.
    Cheng HY; Penninger JM
    Expert Opin Ther Targets; 2003 Apr; 7(2):249-63. PubMed ID: 12667101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repressor DREAM regulates trigeminal noxious perception.
    Benedet T; Gonzalez P; Oliveros JC; Dopazo JM; Ghimire K; Palczewska M; Mellstrom B; Naranjo JR
    J Neurochem; 2017 May; 141(4):544-552. PubMed ID: 26896746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesia induced by dietary restriction is mediated by the kappa-opioid system.
    de los Santos-Arteaga M; Sierra-Domínguez SA; Fontanella GH; Delgado-García JM; Carrión AM
    J Neurosci; 2003 Dec; 23(35):11120-6. PubMed ID: 14657170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No DREAM, No pain. Closing the spinal gate.
    Costigan M; Woolf CJ
    Cell; 2002 Feb; 108(3):297-300. PubMed ID: 11853663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DREAM is a Ca2+-regulated transcriptional repressor.
    Carrión AM; Link WA; Ledo F; Mellström B; Naranjo JR
    Nature; 1999 Mar; 398(6722):80-4. PubMed ID: 10078534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DREAMing about arthritic pain.
    Cheng HY; Penninger JM
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii72-ii75. PubMed ID: 15479877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice.
    Ruiz-DeDiego I; Mellstrom B; Vallejo M; Naranjo JR; Moratalla R
    Biol Psychiatry; 2015 Jan; 77(2):95-105. PubMed ID: 24857398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice.
    Negrete R; García Gutiérrez MS; Manzanares J; Maldonado R
    Neuropharmacology; 2017 Apr; 116():315-327. PubMed ID: 27567942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calsenilin interacts with transcriptional co-repressor C-terminal binding protein(s).
    Zaidi NF; Kuplast KG; Washicosky KJ; Kajiwara Y; Buxbaum JD; Wasco W
    J Neurochem; 2006 Aug; 98(4):1290-301. PubMed ID: 16787403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal distribution of c-Fos activated neurons expressing enkephalin in acute and chronic pain models.
    Hossaini M; Duraku LS; Kohli SK; Jongen JL; Holstege JC
    Brain Res; 2014 Jan; 1543():83-92. PubMed ID: 24231552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of downstream regulatory element antagonist modulator (DREAM) in rat spinal cord and upregulation of its expression during inflammatory pain.
    Zhang Y; Li Y; Yang YR; Zhu HH; Han JS; Wang Y
    Neurochem Res; 2007 Sep; 32(9):1592-9. PubMed ID: 17562172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increases in mRNA and DREAM protein expression in the rat spinal cord after formalin induced pain.
    Long I; Suppian R; Ismail Z
    Neurochem Res; 2011 Mar; 36(3):533-9. PubMed ID: 21188515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca(2+)-dependent prodynorphin transcriptional derepression in neuroblastoma cells is exerted through DREAM protein activity in a kinase-independent manner.
    Campos D; Jiménez-Díaz L; Carrión AM
    Mol Cell Neurosci; 2003 Feb; 22(2):135-45. PubMed ID: 12676525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate activates c-fos in glial cells via a novel mechanism involving the glutamate receptor subtype mGlu5 and the transcriptional repressor DREAM.
    Edling Y; Ingelman-Sundberg M; Simi A
    Glia; 2007 Feb; 55(3):328-40. PubMed ID: 17120244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of the Ca2+-binding protein DREAM with presenilin in neuronal Ca2+ signaling.
    Fedrizzi L; Lim D; Carafoli E; Brini M
    J Biol Chem; 2008 Oct; 283(41):27494-27503. PubMed ID: 18664571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DREAM regulates BDNF-dependent spinal sensitization.
    Rivera-Arconada I; Benedet T; Roza C; Torres B; Barrio J; Krzyzanowska A; Avendaño C; Mellström B; Lopez-Garcia JA; Naranjo JR
    Mol Pain; 2010 Dec; 6():95. PubMed ID: 21167062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.